When should SBRT be offered to oligometastatic bone disease in a patient with prostate cancer?   

What factors should be considered with offering SBRT to oligometastatic bone disease in prostate cancer patients? Should this been done off of a protocol?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Academic Institution